Profile for United States of America Patent: 2012073571
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for United States of America Patent: 2012073571
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
⤷ Sign Up | Aug 18, 2025 | Currax | ONZETRA XSAIL | sumatriptan succinate |
⤷ Sign Up | Dec 29, 2025 | Optinose Us Inc | XHANCE | fluticasone propionate |
⤷ Sign Up | Apr 20, 2024 | Optinose Us Inc | XHANCE | fluticasone propionate |
⤷ Sign Up | Apr 23, 2024 | Currax | ONZETRA XSAIL | sumatriptan succinate |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |